Patents-Review.com
ClassID:

116409 ⎘

C12Y301/06004 - CPC Classification

Classification description:

Hydrolases acting on ester bonds (3.1); Sulfuric ester hydrolases (3.1.6) N-Acetylgalactosamine-6-sulfatase (3.1.6.4)

Recent Application in this class:
#1
20260048148
2026-02-19

GENE THERAPY

 #2
20250075194
2025-03-06

ADENOASSOCIATED VIRUS VECTORS FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSES TYPE IV A

 #3
20230085357
2023-03-16

INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF

 #4
20230064077
2023-03-02

TREATMENT OF MUCOPOLYSACCHARIDOSIS IVA

 #5
20220259577
2022-08-18

Chondrosulphatase and use thereof

 #6
20210292789
2021-09-23

Treatment of mucopolysaccharidosis IVA

 #7
20210260172
2021-08-26

Method of treating mucopolysaccharidosis type IVA

 #8
20210214695
2021-07-15

Adenoassociated virus vectors for the treatment of mucopolysaccharidoses type IV A

 #9
20210198653
2021-07-01

DELIVERING ENZYME USING AN INJECTABLE HYDROGEL DEPOT

 #10
20200032229
2020-01-30

Reduced immunogenic proteins for lysosomal storage disorders

 #11
20190224283
2019-07-25

Method of treating mucopolysaccharidosis type IVA

 #12
20190192693
2019-06-27

METHODS AND VECTORS FOR TREATING CNS DISORDERS

 #13
20190127726
2019-05-02

Delivering enzyme using an injectable hydrogel depot

 #14
20190117846
2019-04-25

Combined treatment for nerve injuries

 #15
20180073000
2018-03-15

Reduced immunogenic proteins for lysosomal storage disorders

 #16
20160186149
2016-06-30

Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

 #17
20140341878
2014-11-20

Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

 #18
20120189605
2012-07-26

Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof